WHO ICTRP trial
Gender differences in pain medicine: from genetics to healthcare.
EUCTR2021-001238-21-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-001238-21-ES |
|---|---|
| Public title | Gender differences in pain medicine: from genetics to healthcare. |
| Scientific title | Gender biases in pain medicine: from omics to healthcare. - SESGEN |
| Primary sponsor | Institute of Health and Biomedical Research of Alicante |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Spain |
| Conditions | The medical condition to be evaluated is the analgesic response of people with chronic low back pain who are going to be treated with opioids, guided by omics sciences (pharmacogenetics, epigenetics and metabolomics).;Therapeutic area… |
| Interventions | Product Name: Morphine Pharmaceutical Form: Compressed lozenge INN or Proposed INN: MORPHINE SULFATE CAS Number: 64-31-3 Other descriptive name: MORPHINE SULFATE Product Name: Fentanyl Pharmaceutical Form: Transdermal patch INN or Proposed… |
| Registration date | Nov 6, 2021 |
| Target size | 500 |
| Secondary IDs | 2020-SESGEN |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: